The influence of angiotensin-(1-7) Mas receptor agonist (AVE 0991) on mitochondrial proteome in kidneys of apoE knockout mice

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1834, Issue 12, 2013, Pages 2463-2469

  Suski, Maciej ^a   Olszanecki, Rafał ^a   Stachowicz, Aneta ^a   Madej, Józef ^a   Bujak Gizycka, Beata ^a   Okoń, Krzysztof ^a   Korbut, Ryszard ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Angiotensin (1 7); Apolipoprotein E; Kidney; Mitochondrion; Proteomics

Indexed keywords

APOLIPOPROTEIN E; MITOCHONDRIAL PROTEIN; N ETHYLCARBAMOYL 3 [4 (5 FORMYL 4 METHOXY 2 PHENYL 1 IMIDAZOLYLMETHYL)PHENYL] 5 ISOBUTYL 2 THIOPHENESULFONAMIDE; PROTEOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; KIDNEY; KNOCKOUT MOUSE; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALIA; MUS;

EID: 84884621856     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2013.08.008     Document Type: Article

References (71)

1. A.S. Levey, R. Atkins, J. Coresh, E.P. Cohen, A.J. Collins, K.U. Eckardt, M.E. Nahas, B.L. Jaber, M. Jadoul, A. Levin, N.R. Powe, J. Rossert, D.C. Wheeler, N. Lameire, and G. Eknoyan Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes Kidney Int. 72 2007 247 259 (Pubitemid 47172384)
2. A.R. Chade, A. Lerman, and L.O. Lerman Kidney in early atherosclerosis Hypertension 45 2005 1042 1049 (Pubitemid 40770301)
3. A.J. Collins, S. Li, D.T. Gilbertson, J. Liu, S.C. Chen, and C.A. Herzog Chronic kidney disease and cardiovascular disease in the Medicare population Kidney Int. Suppl. 2003 S24 S31
4. R.N. Re, and J.L. Cook The mitochondrial component of intracrine action Am. J. Physiol. Heart Circ. Physiol. 299 2010 H577 H583
5. E.M. de Cavanagh, F. Inserra, M. Ferder, and L. Ferder From mitochondria to disease: role of the renin-angiotensin system Am. J. Nephrol. 27 2007 545 553 (Pubitemid 350014941)
6. A.E. Dikalova, A.T. Bikineyeva, K. Budzyn, R.R. Nazarewicz, L. McCann, W. Lewis, D.G. Harrison, and S.I. Dikalov Therapeutic targeting of mitochondrial superoxide in hypertension Circ. Res. 107 2010 106 116
7. S. Granata, G. Zaza, S. Simone, G. Villani, D. Latorre, P. Pontrelli, M. Carella, F.P. Schena, G. Grandaliano, and G. Pertosa Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease BMC Genomics 10 2009 388
8. A.B. Sanz, B. Santamaria, M. Ruiz-Ortega, J. Egido, and A. Ortiz Mechanisms of renal apoptosis in health and disease J. Am. Soc. Nephrol. 19 2008 1634 1642
9. J.M. Weinberg Mitochondrial biogenesis in kidney disease J. Am. Soc. Nephrol. 22 2011 431 436
10. S.D. Crowley, S.B. Gurley, M.I. Oliverio, A.K. Pazmino, R. Griffiths, P.J. Flannery, R.F. Spurney, H.S. Kim, O. Smithies, T.H. Le, and T.M. Coffman Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system J. Clin. Investig. 115 2005 1092 1099 (Pubitemid 40489414)
11. V. Raizada, B. Skipper, W. Luo, and J. Griffith Intracardiac and intrarenal renin-angiotensin systems: mechanisms of cardiovascular and renal effects J. Investig. Med. 55 2007 341 359 (Pubitemid 351216906)
12. U.C. Brewster, J.F. Setaro, and M.A. Perazella The renin-angiotensin- aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states Am. J. Med. Sci. 326 2003 15 24 (Pubitemid 36870293)
13. J.L. Zhuo, and X.C. Li New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II Peptides 32 2011 1551 1565
14. M. Sata, and D. Fukuda Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis J. Med. Investig. 57 2010 12 25
15. B. Erdmann, K. Fuxe, and D. Ganten Subcellular localization of angiotensin II immunoreactivity in the rat cerebellar cortex Hypertension 28 1996 818 824 (Pubitemid 26365524)
16. B. Piotrkowski, C.G. Fraga, and E.M. de Cavanagh Mitochondrial function and nitric oxide metabolism are modified by enalapril treatment in rat kidney Am. J. Physiol. Regul. Integr. Comp. Physiol. 292 2007 R1494 R1501
17. E.M. de Cavanagh, L. Ferder, J.E. Toblli, B. Piotrkowski, I. Stella, C.G. Fraga, and F. Inserra Renal mitochondrial impairment is attenuated by AT1 blockade in experimental Type I diabetes Am. J. Physiol. Heart Circ. Physiol. 294 2008 H456 H465
18. E.M. de Cavanagh, J.E. Toblli, L. Ferder, B. Piotrkowski, I. Stella, and F. Inserra Renal mitochondrial dysfunction in spontaneously hypertensive rats is attenuated by losartan but not by amlodipine Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 2006 R1616 R1625
19. P.M. Abadir, D.B. Foster, M. Crow, C.A. Cooke, J.J. Rucker, A. Jain, B.J. Smith, T.N. Burks, R.D. Cohn, N.S. Fedarko, R.M. Carey, B. O'Rourke, and J.D. Walston Identification and characterization of a functional mitochondrial angiotensin system Proc. Natl. Acad. Sci. U. S. A. 108 2011 14849 14854
20. C.A. Nguyen Dinh, and R.M. Touyz A new look at the renin-angiotensin system - focusing on the vascular system Peptides 32 2011 2141 2150
21. K.E. Bernstein Views of the renin-angiotensin system: brilling, mimsy, and slithy tove Hypertension 47 2006 509 514 (Pubitemid 43843867)
22. J. Varagic, A.J. Trask, J.A. Jessup, M.C. Chappell, and C.M. Ferrario New angiotensins J. Mol. Med. (Berl) 86 2008 663 671
23. K. Kramkowski, A. Mogielnicki, and W. Buczko The physiological significance of the alternative pathways of angiotensin II production J. Physiol. Pharmacol. 57 2006 529 539 (Pubitemid 46096103)
24. C.M. Ferrario, S. Ahmad, J. Joyner, and J. Varagic Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7) Adv. Pharmacol. 59 2010 197 233 (197-233)
25. C.M. Ferrario, and J. Varagic The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function Am. J. Physiol. Renal Physiol. 298 2010 F1297 F1305
26. S.V. Pinheiro, and Simoes E. Silva AC Angiotensin converting enzyme 2, angiotensin-(1-7), and receptor MAS axis in the kidney Int. J. Hypertens. 2012 414128 (Epub;%2012 Feb 8, 414128 (2012))
27. A. Shah, Y.B. Oh, S.H. Lee, J.M. Lim, and S.H. Kim Angiotensin-(1-7) attenuates hypertension in exercise-trained renal hypertensive rats Am. J. Physiol. Heart Circ. Physiol. 302 2012 H2372 H2380
28. C. Tikellis, S. Bernardi, and W.C. Burns Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease Curr. Opin. Nephrol. Hypertens. 19 2010
29. D. Zimmerman, and K.D. Burns Angiotensin-(1-7) in kidney disease: a review of the controversies Clin. Sci. (Lond.) 123 2012 333 346
30. N. Grobe, K.M. Elased, D.R. Cool, and M. Morris Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney Am. J. Physiol. Endocrinol. Metab. 302 2012 E1016 E1024
31. L.S. Lara, D. Vives, J.S. Correa, F.P. Cardozo, M.F. Marques-Fernades, A.G. Lopes, and C. Caruso-Neves PKA-mediated effect of MAS receptor in counteracting angiotensin II-stimulated renal Na +-ATPase Arch. Biochem. Biophys. 496 2010 117 122
32. K.S. Meir, and E. Leitersdorf Atherosclerosis in the apolipoprotein-E- deficient mouse: a decade of progress Arterioscler. Thromb. Vasc. Biol. 24 2004 1006 1014 (Pubitemid 38737824)
33. R. Yang, L. Powell-Braxton, A.K. Ogaoawara, N. Dybdal, S. Bunting, O. Ohneda, and H. Jin Hypertension and endothelial dysfunction in apolipoprotein E knockout mice Arterioscler. Thromb. Vasc. Biol. 19 1999 2762 2768 (Pubitemid 29536055)
34. M. Wen, S. Segerer, M. Dantas, P.A. Brown, K.L. Hudkins, T. Goodpaster, E. Kirk, R.C. LeBoeuf, and C.E. Alpers Renal injury in apolipoprotein E-deficient mice Lab. Investig. 82 2002 999 1006
35. C.K. Abrass Cellular lipid metabolism and the role of lipids in progressive renal disease Am. J. Nephrol. 24 2004 46 53 (Pubitemid 38258276)
36. T. Takaya, S. Kawashima, M. Shinohara, T. Yamashita, R. Toh, N. Sasaki, N. Inoue, K. Hirata, and M. Yokoyama Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice Atherosclerosis 186 2006 402 410
37. D. Fukuda, S. Enomoto, R. Nagai, and M. Sata Inhibition of renin-angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation Biomed. Pharmacother. 63 2009 754 761
38. J. Jawien, J. Toton-Zuranska, M. Gajda, A. Niepsuj, A. Gebska, K. Kus, M. Suski, G. Pyka-Fosciak, B. Nowak, T.J. Guzik, J. Marcinkiewicz, R. Olszanecki, and R. Korbut Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice J. Physiol. Pharmacol. 63 2012 77 85
39. J. Toton-Zuranska, M. Gajda, G. Pyka-Fosciak, K. Kus, M. Pawlowska, A. Niepsuj, P. Wolkow, R. Olszanecki, J. Jawien, and R. Korbut AVE 0991-angiotensin-(1-7) receptor agonist, inhibits atherogenesis in apoE-knockout mice J. Physiol. Pharmacol. 61 2010 181 183
40. L.C. Barroso, K.D. Silveira, C.X. Lima, V. Borges, M. Bader, M. Rachid, R.A. Santos, D.G. Souza, Simoes E. Silva AC, and M.M. Teixeira Renoprotective effects of AVE0991, a nonpeptide mas receptor agonist, in experimental acute renal injury Int. J. Hypertens. 2012 808726 (Epub;%2012 Jan 29., 808726 (2012))
41. A. Stachowicz, M. Suski, R. Olszanecki, J. Madej, K. Okon, and R. Korbut Proteomic analysis of liver mitochondria of apolipoprotein E knockout mice treated with metformin J. Proteomics 77 2012 167 175
42. M. Suski, R. Olszanecki, J. Madej, J. Toton-Zuranska, A. Niepsuj, J. Jawien, B. Bujak-Gizycka, K. Okon, and R. Korbut Proteomic analysis of changes in protein expression in liver mitochondria in apoE knockout mice J. Proteomics 74 2011 887 893
43. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254 (248-254)
44. J.X. Yan, R. Wait, T. Berkelman, R.A. Harry, J.A. Westbrook, C.H. Wheeler, and M.J. Dunn A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry Electrophoresis 21 2000 3666 3672
45. A. Shevchenko, H. Tomas, J. Havlis, J.V. Olsen, and M. Mann In-gel digestion for mass spectrometric characterization of proteins and proteomes Nat. Protoc. 1 2006 2856 2860
46. L.A. Macmillan-Crow, and D.L. Cruthirds Invited review: manganese superoxide dismutase in disease Free Radic. Res. 34 2001 325 336 (Pubitemid 32331659)
47. Z. Cao, J.G. Lindsay, and N.W. Isaacs Mitochondrial peroxiredoxins Subcell. Biochem. 44 2007 295 315 (295-315)
48. A.G. Cox, C.C. Winterbourn, and M.B. Hampton Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling Biochem. J. 425 2009 313 325
49. J.R. Bamburg, and O.P. Wiggan ADF/cofilin and actin dynamics in disease Trends Cell Biol. 12 2002 598 605 (Pubitemid 35461859)
50. B.T. Chua, C. Volbracht, K.O. Tan, R. Li, V.C. Yu, and P. Li Mitochondrial translocation of cofilin is an early step in apoptosis induction Nat. Cell Biol. 5 2003 1083 1089 (Pubitemid 37509115)
51. T. Asakura, and K. Ohkawa Chemotherapeutic agents that induce mitochondrial apoptosis Curr. Cancer Drug Targets 4 2004 577 590 (Pubitemid 39536378)
52. J.L. York, L.C. Maddox, P. Zimniak, T.E. McHugh, and D.F. Grant Reduction of MTT by glutathione S-transferase Biotechniques 25 1998 622 628 (Pubitemid 28465691)
53. T. Asakura, A. Sasagawa, H. Takeuchi, S. Shibata, H. Marushima, S. Mamori, and K. Ohkawa Conformational change in the active center region of GST P1-1, due to binding of a synthetic conjugate of DXR with GSH, enhanced JNK-mediated apoptosis Apoptosis 12 2007 1269 1280 (Pubitemid 46890383)
54. F.Y. Ma, J. Liu, and D.J. Nikolic-Paterson The role of stress-activated protein kinase signaling in renal pathophysiology Braz. J. Med. Biol. Res. 42 2009 29 37
55. P. Hauser, and R. Oberbauer Tubular apoptosis in the pathophysiology of renal disease Wien. Klin. Wochenschr. 114 2002 671 677 (Pubitemid 35033588)
56. G.A. Kaysen Biochemistry and biomarkers of inflamed patients: why look, what to assess Clin. J. Am. Soc. Nephrol. 4 Suppl. 1 2009 S56 S63 (S56-S63)
57. J.L. Sullivan Iron in arterial plaque: modifiable risk factor for atherosclerosis Biochim. Biophys. Acta 1790 2009 718 723
58. M. Merk, S. Zierow, L. Leng, R. Das, X. Du, W. Schulte, J. Fan, H. Lue, Y. Chen, H. Xiong, F. Chagnon, J. Bernhagen, E. Lolis, G. Mor, O. Lesur, and R. Bucala The d-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF) Proc. Natl. Acad. Sci. U. S. A. 108 2011 E577 E585
59. H. Sugimoto, M. Taniguchi, A. Nakagawa, I. Tanaka, M. Suzuki, and J. Nishihira Crystal structure of human d-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution Biochemistry 38 1999 3268 3279
60. H.Y. Lan Role of macrophage migration inhibition factor in kidney disease Nephron Exp. Nephrol. 109 2008 e79 e83
61. A. Javeed, Y. Zhao, and Y. Zhao Macrophage-migration inhibitory factor: role in inflammatory diseases and graft rejection Inflamm. Res. 57 2008 45 50 (Pubitemid 351302062)
62. B. Hoppe, B.B. Beck, and D.S. Milliner The primary hyperoxalurias Kidney Int. 75 2009 1264 1271
63. M. Tuncdemir, O. Demirkesen, M. Ozturk, P. Atukeren, M.K. Gumustas, and T. Turan Antiapoptotic effect of angiotensin-II type-1 receptor blockade in renal tubular cells of hyperoxaluric rats Urol. Res. 38 2010 71 80
64. J. Martin, F. Magnino, K. Schmidt, A.C. Piguet, J.S. Lee, D. Semela, M.V. St Pierre, A. Ziemiecki, D. Cassio, C. Brenner, S.S. Thorgeirsson, and J.F. Dufour Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma Gastroenterology 130 2006 2179 2188 (Pubitemid 43816955)
65. E.M. de Cavanagh, F. Inserra, and L. Ferder Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria? Cardiovasc. Res. 89 2011 31 40
66. C.T. Supuran Carbonic anhydrases - an overview Curr. Pharm. Des. 14 2008 603 614
67. J.M. Purkerson, and G.J. Schwartz The role of carbonic anhydrases in renal physiology Kidney Int. 71 2007 103 115 (Pubitemid 46094683)
68. G.N. Shah, D. Hewett-Emmett, J.H. Grubb, M.C. Migas, R.E. Fleming, A. Waheed, and W.S. Sly Mitochondrial carbonic anhydrase CA VB: differences in tissue distribution and pattern of evolution from those of CA VA suggest distinct physiological roles Proc. Natl. Acad. Sci. U. S. A. 97 2000 1677 1682 (Pubitemid 30118502)
69. S.J. Dodgson, and R.E. Forster Inhibition of CA V decreases glucose synthesis from pyruvate Arch. Biochem. Biophys. 251 1986 198 204 (Pubitemid 17192998)
70. J. Zhao, and C.J. Zhong A review on research progress of transketolase Neurosci. Bull. 25 2009 94 99
71. J.A. Vizcaino, R.G. Cote, A. Csordas, J.A. Dianes, A. Fabregat, J.M. Foster, J. Griss, E. Alpi, M. Birim, J. Contell, G. O'Kelly, A. Schoenegger, D. Ovelleiro, Y. Perez-Riverol, F. Reisinger, D. Rios, R. Wang, and H. Hermjakob The Proteomics Identifications (PRIDE) database and associated tools: status in 2013 Nucleic Acids Res. 41 D1 Jan 1 2013 D1063 D1069